Table 1 Clinicopathologic significance of SBF2-AS1 in human cancers
From: Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers
Cancer type | Expression | Sample numbers | Clinicopathologic features | Refs. |
|---|---|---|---|---|
Acute myeloid leukemia | Upregulated | 173 cancer samples 70 normal samples | Overall survival | [38] |
Breast cancer | Upregulated | 50 paired samples | Lymph node metastasis, tumor size, clinical stage | [35] |
Lung cancer | Upregulated | 50 paired samples | Overall survival | [47] |
41 paired samples | Lymph node stage, TNM stage | [26] | ||
174 paired samples | Histological grade, lymph node metastasis, overall survival | [124] | ||
56 paired samples | TNM stage, lymph node metastasis, Overall survival | [50] | ||
35 paired samples | Age, tumor size, tumor tissue type, TNM stage, Overall survival | [46] | ||
30 normal samples 30 NSCLC samples 96 SCLC samples | Extensive stage, tumor size > 3 cm, lymph node metastasis, distant metastasis, overall survival | [125] | ||
Osteosarcoma | Upregulated | 45 paired samples | Tumor size, distant metastasis, ennking stage | [44] |
Pancreatic cancer | Upregulated | 82 paired samples | Degree of differentiation, TNM stage, lymph Node metastasis | [27] |
Cervical cancer | Upregulated | 66 paired | FIGOa stage, lymph node metastasis, overall survival | [39] |
Colorectal cancer | Upregulated | 61 cancer samples 29 normal samples | TNM stages, survival rate | [30] |
Papillary thyroid cancer | Upregulated | 73 tumor samples (37 high and 36 low) | Overall survival | [40] |
Glioblastoma | Upregulated | 47 tumor samples 5 normal samples | Pathological grade | [36] |
20 primary samples 20 recurrent samples | Overall survival | [37] | ||
Clear cell renal cell carcinoma | Upregulated | 46 paired | – | [41] |
Hepatocellular carcinoma | Upregulated | 184 paired samples | Lymph node metastasis, histologic grade, TNM stage, overall survival | [28] |
134 paired samples | Vein invasion, TNM stage, overall survival rate | [29] | ||
Gastric cancer | Upregulated | 60 paired samples | TNM stage, overall survival | [31] |
Esophageal squamous cell carcinoma | Upregulated | 51 paired samples | Smoking and drinking history, tumor size, TNM stages, survival rate | [32] |
50 tumor samples 15 normal samples | Survival rate | [33] | ||
50 paired samples | Tumor size, survival rate | [34] |